miércoles, 9 de octubre de 2019

ICER says drug price hikes without proof of new benefits cost U.S. $5.1b

ICER says drug price hikes without proof of new benefits cost U.S. $5.1b

Daily Recap

STAT Plus: ICER says price hikes on 7 drugs were made without proof of new benefits, costing the U.S. $5.1 billion

By ED SILVERMAN


DAVID J. PHILLIP/AP
“The findings show that a lot of manufacturers are raising prices by a lot, year over year, because they can,” said Dr. David Rind at ICER.

No hay comentarios: